Open Angle Glaucoma. Open-angle glaucoma
Conditions
Interventions
Intervention 1: Intervention group: In this method, first subthenon injection of 0.1 ml of mitomycin C 0.2 mg / ml is performed and after conjugate massage, the flap is removed. Continuation of the su
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with open-angle glaucoma (OAG) with advanced caping and progressive visual field defects A patient with open-angle glaucoma (OAG) who needs medication to control IOP but does not tolerate medication Patients with open-angle glaucoma (OAG) whose IOP is not well controlled despite medication. Patients with open-angle glaucoma (OAG) who need multiple medications to control IOP Willingness to participate in the study (patients with informed consent)
Exclusion criteria
Exclusion criteria: Lack of proper access to the patient for long-term follow-up Patients with any congenital abnormality of the anterior chamber angle Patients with ocular infections Patients with a history of ocular surgery Patients with uveitis Patients with corneal diseases that can affect IOP or measure it (corneal opacity, large pterygium, etc.). Patients with diabetes and hypertension Patients with neovascular glaucoma In case of any ocular or systemic complications, patients are excluded from the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraocular pressure. Timepoint: Before surgery (one day, 2 weeks, 1 month, 2 months, 3 months, 6 months, after surgery). Method of measurement: Using a Goldman tonometer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Bleb apperance. Timepoint: 2 months, 3 months, 6 months after surgery. Method of measurement: IBAG(indiana Bleb Grading Scale). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Mostafaei
Tabriz University of Medical Sciences
Outcome results
None listed